PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
46.92
ESG score 40-50 - Concerning ESG levels. Seth Klarman would demand significant margin of safety given potential regulatory and reputational risks.
27.98
Environmental score below 40 - Climate danger zone. Howard Marks would warn of potential stranded assets and carbon tax exposure. Essential to examine transition planning.
55.48
Social score 50-60 - Below-average social territory. Benjamin Graham would scrutinize reputational risks and potential litigation exposure from stakeholder issues.
57.30
Governance score 50-60 - Below-average governance territory. Benjamin Graham would scrutinize management entrenchment and potential agency costs.